Literature DB >> 26098014

Musculoskeletal pain may be associated with imatinib withdrawal syndrome in chronic myeloid leukemia patients.

Yoshimi Ishii1, Maki Hagihara1, Ai Kato1, Taiki Ando1, Megumi Itabashi1, Satoshi Koyama1, Wataru Yamamoto1, Kenji Motohashi1, Kenji Matsumoto1, Shin Fujisawa1.   

Abstract

Entities:  

Year:  2015        PMID: 26098014     DOI: 10.3109/10428194.2015.1064531

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


× No keyword cloud information.
  2 in total

1.  Up-regulated exosomal miRNA-140-3p in CML patients with musculoskeletal pain associated with discontinuation of tyrosine kinase inhibitors.

Authors:  Michiyo Asano; Tomohiro Umezu; Seiichiro Katagiri; Chiaki Kobayashi; Tetsuzo Tauchi; Moritaka Gotoh; Keiko Ando; Seiichi Okabe; Junko H Ohyashiki; Kazuma Ohyashiki
Journal:  Int J Hematol       Date:  2017-02-14       Impact factor: 2.490

Review 2.  Current status of ABL tyrosine kinase inhibitors stop studies for chronic myeloid leukemia.

Authors:  Shinya Kimura
Journal:  Stem Cell Investig       Date:  2016-08-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.